# Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma

> **NCT06112847** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 29 (actual)

## Conditions studied

- Follicular Lymphoma

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Bone Marrow Biopsy
- **PROCEDURE:** Computed Tomography
- **OTHER:** Electronic Health Record Review
- **BIOLOGICAL:** Epcoritamab
- **DRUG:** Lenalidomide
- **PROCEDURE:** Magnetic Resonance Imaging
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT06112847
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-01-24
- **Primary completion:** 2026-07-17
- **Final completion:** 2026-07-17
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06112847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06112847, "Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06112847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*